The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 ...

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million ...

There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.

The U.S. Supreme Court on Monday rejected appeals from two high-profile figures: R&B singer R. Kelly, and former pharmaceutical executive Martin Shkreli, known as "Pharma Bro." Kelly, who is serving a ...

The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli's challenge to a $64 ...

The U.S. Supreme Court refused to hear Martin Shkreli's appeal against a $64.6 million penalty imposed for steeply raising a ...

The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has ended with a ...

The Supreme Court rejected appeals in high-profile cases regarding singer R. Kelly, Martin Shkreli and a former Texas police ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...

Martin Shkreli in 2022 was banned from the pharmaceutical industry and ordered to disgorge profits earned from raising the ...

Mr. Shkreli was convicted of defrauding investors and sentenced in 2018 to seven years in prison; he served about five years. A federal judge also banned Mr. Shkreli from the pharmaceutical industry ...

The Supreme Court declined to hear Martin Shkreli's appeal against a $64.6 million penalty for raising a drug's price by over ...